{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T03:00:24Z","timestamp":1773889224737,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000865","name":"Gates Foundation","doi-asserted-by":"publisher","award":["OPP1209963"],"award-info":[{"award-number":["OPP1209963"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.vaccine.2025.128064","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T10:04:08Z","timestamp":1764842648000},"page":"128064","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pneumococcal carriage among children and adults before and after a change from a three-dose 13-valent pneumococcal conjugate vaccine schedule without a booster to a two-dose schedule with a booster in Burkina Faso"],"prefix":"10.1016","volume":"72","author":[{"given":"Lana","family":"Childs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert Lamoussa","family":"Zoma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issa","family":"Ouedraogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guetwend\u00e9","family":"Sawadogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. F\u00e9lix","family":"Tarbangdo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aristide","family":"Zoma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumeya","family":"Ouangraoua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"Dama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahmina","family":"Akhter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simran","family":"Utreja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahamoudou","family":"Ouattara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer R.","family":"Verani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soufiane","family":"Sanou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Flavien","family":"Ak\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesley","family":"McGee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miwako","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.128064_bb0005","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S1473-3099(24)00176-2","article-title":"Infections GBDLR, Antimicrobial Resistance C. Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the global burden of disease study 2021","volume":"24","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128064_bb0010","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiab105","article-title":"Pneumococcal meningitis outbreaks in Africa, 2000-2018: systematic literature review and meningitis surveillance database analyses","volume":"224","author":"Franklin","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128064_bb0015","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1586\/erv.12.53","article-title":"The fundamental link between pneumococcal carriage and disease","volume":"11","author":"Simell","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.128064_bb0020","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1473-3099(24)00665-0","article-title":"Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysis","volume":"25","author":"Bennett","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128064_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(16)30306-0","article-title":"Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis","volume":"5","author":"Shiri","year":"2017","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2025.128064_bb0030","first-page":"85","article-title":"Pneumococcal conjugate vaccines in infants and children under 5 years of age: WHO position paper","volume":"94","author":"World Health Organization","year":"2019","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2025.128064_bb0040","article-title":"Pneumococcal carriage in Burkina Faso after 13-valent pneumococcal conjugate vaccine introduction and before a schedule change. Open forum","volume":"11","author":"Childs","year":"2024","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.vaccine.2025.128064_bb0045","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa856","article-title":"Persistent and emerging pneumococcal carriage serotypes in a rural Gambian community after 10 years of pneumococcal conjugate vaccine pressure","volume":"73","author":"Usuf","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128064_bb0050","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1038\/s41467-020-15786-9","article-title":"High residual carriage of vaccine-serotype Streptococcus pneumoniae after introduction of pneumococcal conjugate vaccine in Malawi","volume":"11","author":"Swarthout","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2025.128064_bb0055","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiz301","article-title":"Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis, Burkina Faso, 2016-2017","volume":"220","author":"Soeters","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128064_bb0065","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiab037","article-title":"Pneumococcal carriage in Burkina Faso after 13-valent pneumococcal conjugate vaccine introduction: results from 2 cross-sectional population-based surveys","volume":"224","author":"Kabore","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128064_bb0075","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.vaccine.2013.08.062","article-title":"Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization pneumococcal carriage working group","volume":"32","author":"Satzke","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128064_bb0090","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2025.128064_bb0095","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/aje\/kwi188","article-title":"Easy SAS calculations for risk or prevalence ratios and differences","volume":"162","author":"Spiegelman","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2025.128064_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2021.11.021","article-title":"Pneumococcal carriage among children in low and lower-middle-income countries: a systematic review","volume":"115","author":"Tvedskov","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128064_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.126954","article-title":"Comparison of Streptococcus pneumoniae nasopharyngeal colonization, serotype-specific and protein-specific antibody and cytokine levels in young children prior to, during and post COVID-19 pandemic","volume":"54","author":"Fuji","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128064_bb0110","article-title":"Pandemic social distancing and declines in nasopharyngeal carriage of pneumococcus and related Antimicrobial-resistant genes: evidence from household-based cohort studies in Lima, Peru. Open forum","volume":"12","author":"Charnogursky","year":"2025","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.vaccine.2025.128064_bb0115","article-title":"Infant pneumococcal carriage in Belgium not affected by COVID-19 containment measures","volume":"11","author":"Willen","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2025.128064_bb0120","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciab1014","article-title":"Decline in pneumococcal disease in young children during the coronavirus disease 2019 (COVID-19) pandemic in Israel associated with suppression of seasonal respiratory viruses, despite persistent pneumococcal carriage: a prospective cohort study","volume":"75","author":"Danino","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2025.128064_bb0125","article-title":"Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization","volume":"33","author":"Loo","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2025.128064_bb0130","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/cid\/ciz285","article-title":"Impact of 10-valent pneumococcal conjugate vaccine introduction on pneumococcal carriage and antibiotic susceptibility patterns among children aged <5 years and adults with human immunodeficiency virus infection: Kenya, 2009-2013","volume":"70","author":"Kobayashi","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128064_bb0135","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/aje\/kwx048","article-title":"Imputing the direct and indirect effectiveness of childhood pneumococcal conjugate vaccine against invasive pneumococcal disease by surveying temporal changes in nasopharyngeal pneumococcal colonization","volume":"186","author":"Nzenze","year":"2017","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2025.128064_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001107","article-title":"Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial","volume":"8","author":"Roca","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2025.128064_bb0145","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1016\/j.vaccine.2024.02.066","article-title":"Impact of pneumococcal conjugate vaccination on pneumococcal nasopharyngeal carriage in the Gambia: population-based cross-sectional surveys","volume":"42","author":"Mackenzie","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128064_bb0150","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s40121-023-00798-x","article-title":"Historical population-level impact of infant 13-valent pneumococcal conjugate vaccine (PCV13) National Immunization Programs on invasive pneumococcal disease in Australia, Canada, England and Wales, Israel, and the United States","volume":"12","author":"Perdrizet","year":"2023","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.vaccine.2025.128064_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.07.021","article-title":"Long-term impact of 10-valent pneumococcal conjugate vaccine in Kenya: nasopharyngeal carriage among children in a rural and an urban site six years after introduction","volume":"42","author":"Verani","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128064_bb0160","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/cid\/cit428","article-title":"Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial","volume":"57","author":"Dagan","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128064_bb0165","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1473-3099(14)70822-9","article-title":"Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study","volume":"14","author":"Andrews","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128064_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(24)00263-8","article-title":"Long-term effect of pneumococcal conjugate vaccines on invasive pneumococcal disease incidence among people of all ages from national, active, laboratory-based surveillance in South Africa, 2005-19: a cohort observational study","volume":"12","author":"von Gottberg","year":"2024","journal-title":"Lancet Glob Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25013623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25013623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:02:45Z","timestamp":1773874965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25013623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":29,"alternative-id":["S0264410X25013623"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128064","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pneumococcal carriage among children and adults before and after a change from a three-dose 13-valent pneumococcal conjugate vaccine schedule without a booster to a two-dose schedule with a booster in Burkina Faso","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128064"}}